BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 159 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $364,000 | +70.1% | 117,506 | +96.7% | 0.00% | 0.0% |
Q2 2021 | $214,000 | -56.7% | 59,726 | -52.8% | 0.00% | -66.7% |
Q1 2021 | $494,000 | +67.5% | 126,447 | +79.9% | 0.00% | +50.0% |
Q4 2020 | $295,000 | -54.5% | 70,277 | -59.6% | 0.00% | -77.8% |
Q3 2020 | $649,000 | +3.7% | 173,908 | +21.1% | 0.01% | -10.0% |
Q2 2020 | $626,000 | -59.9% | 143,648 | -65.1% | 0.01% | -75.0% |
Q1 2020 | $1,562,000 | -52.5% | 412,022 | -20.8% | 0.04% | +100.0% |
Q4 2019 | $3,288,000 | +52.4% | 520,214 | +1.5% | 0.02% | +5.3% |
Q3 2019 | $2,157,000 | -5.8% | 512,280 | +4.0% | 0.02% | -13.6% |
Q2 2019 | $2,290,000 | +50.2% | 492,529 | +71.1% | 0.02% | +37.5% |
Q1 2019 | $1,525,000 | +937.4% | 287,819 | +625.0% | 0.02% | +700.0% |
Q4 2018 | $147,000 | -34.4% | 39,700 | -58.2% | 0.00% | -85.7% |
Q2 2016 | $224,000 | +67.2% | 95,000 | +129.5% | 0.01% | +40.0% |
Q1 2016 | $134,000 | -17.3% | 41,400 | +22.1% | 0.01% | -44.4% |
Q4 2015 | $162,000 | – | 33,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |